Active	Status	Sponsor type	Region	Phase	Filter
11 Active 8 Inactive 19 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

11 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Penny, William
PREVENTABLE, NCT04262206: Pragmatic Evaluation of Events And Benefits of Lipid-lowering in Older Adults	Recruiting	4	20000	US	Atorvastatin 40 Mg Oral Tablet, Lipitor, Placebo oral tablet	Duke University, National Institute on Aging (NIA), National Heart, Lung, and Blood Institute (NHLBI), Wake Forest University Health Sciences	Cognitive Impairment, Mild, Dementia, Cardiovascular Diseases	12/26	12/26
Narayan, Sanjiv M
NCT02169037: Substrate Versus Trigger Ablation for Paroxysmal Atrial Fibrillation	Recruiting	N/A	120	US	FIRM Ablation, Conventional AF ablation with PVI	University of California, San Diego, National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI)	Atrial Fibrillation	07/22	07/22
RECONFIRM, NCT02456233: Evaluation of Conventional Ablation With or Without Focal Impulse and Rotor Modulation to Eliminate Human AF	Recruiting	N/A	120	US	Conventional AF Ablation with PVI, FIRM-guided ablation plus PVI	Stanford University	Atrial Fibrillation	03/25	12/25
COMPARE_AF, NCT02997254: COMParison of Algorithms for Rotational Evaluation in Atrial Fibrillation	Recruiting	N/A	200	US		Stanford University	Atrial Fibrillation, Abnormal Heart Rhythms	11/25	11/26
NCT05371405: Machine Learning in Atrial Fibrillation	Recruiting	N/A	120	US		Stanford University	Atrial Fibrillation, Arrhythmias, Cardiac	12/25	12/26
NCT05366361: The Dynamics of Human Atrial Fibrillation	Recruiting	N/A	200	US		Stanford University	Atrial Fibrillation, Arrhythmias, Cardiac	12/25	12/26
Krummen, David E
NCT02169037: Substrate Versus Trigger Ablation for Paroxysmal Atrial Fibrillation	Recruiting	N/A	120	US	FIRM Ablation, Conventional AF ablation with PVI	University of California, San Diego, National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI)	Atrial Fibrillation	07/22	07/22
RECONFIRM, NCT02456233: Evaluation of Conventional Ablation With or Without Focal Impulse and Rotor Modulation to Eliminate Human AF	Recruiting	N/A	120	US	Conventional AF Ablation with PVI, FIRM-guided ablation plus PVI	Stanford University	Atrial Fibrillation	03/25	12/25
Hancock, Tiffany
PREVENTABLE, NCT04262206: Pragmatic Evaluation of Events And Benefits of Lipid-lowering in Older Adults	Recruiting	4	20000	US	Atorvastatin 40 Mg Oral Tablet, Lipitor, Placebo oral tablet	Duke University, National Institute on Aging (NIA), National Heart, Lung, and Blood Institute (NHLBI), Wake Forest University Health Sciences	Cognitive Impairment, Mild, Dementia, Cardiovascular Diseases	12/26	12/26
John, Melissa St
PREVENTABLE, NCT04262206: Pragmatic Evaluation of Events And Benefits of Lipid-lowering in Older Adults	Recruiting	4	20000	US	Atorvastatin 40 Mg Oral Tablet, Lipitor, Placebo oral tablet	Duke University, National Institute on Aging (NIA), National Heart, Lung, and Blood Institute (NHLBI), Wake Forest University Health Sciences	Cognitive Impairment, Mild, Dementia, Cardiovascular Diseases	12/26	12/26
Chau, Kieu
PREVENTABLE, NCT04262206: Pragmatic Evaluation of Events And Benefits of Lipid-lowering in Older Adults	Recruiting	4	20000	US	Atorvastatin 40 Mg Oral Tablet, Lipitor, Placebo oral tablet	Duke University, National Institute on Aging (NIA), National Heart, Lung, and Blood Institute (NHLBI), Wake Forest University Health Sciences	Cognitive Impairment, Mild, Dementia, Cardiovascular Diseases	12/26	12/26